ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy by Razelle Kurzrock, Ryosuke Okamura, Shumei Kato, Suzanna Lee, Rebecca E Jimenez, Jason K Sicklick

Get full text

4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists by Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K. Nesline, Sarabjot Pabla, Jeffrey M. Conroy, Paul DePietro, Heidi Ko, Jason K. Sicklick, Razelle Kurzrock

Get full text

Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection by Daisuke Nishizaki, Razelle Kurzrock, Jacob J. Adashek, Ki Hwan Kim, Hyo Jeong Lim, Mina Nikanjam, Ramez N. Eskander, Paul T. Fanta, Ryosuke Okamura, Suzanna Lee, Jason K. Sicklick, Scott M. Lippman, Shumei Kato

Get full text

Defining benchmark values for outcomes of comprehensive resection of primary retroperitoneal liposarcoma: a retrospective multicenter studyResearch in context by Fabio Tirotta, Marco Fiore, Sylvie Bonvalot, Dirk Strauss, Piotr Rutkowski, David E. Gyorki, Winan J. van Houdt, Dario Callegaro, Markus Albertsmeier, Dimitri Tzanis, Ferdinando Cananzi, Jason K. Sicklick, John Mullinax, Michelle Wilkinson, Valerie P. Grignol, Kenneth Cardona, Toufik Bouhadiba, Marko Novak, Sergio Valeri, Mark Fairweather, Samuel J. Ford, Jacek Skoczylas, Hayden Snow, Andrew J. Hayes, James Hodson, Chandrajit P. Raut, Alessandro Gronchi

Get full text